B
LeMaitre Vascular, Inc.
LMAT
$78.82
-$2.50-3.07%
B
Buy
8/15/2024Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 8/15/2024 due to an increase in the valuation index, growth index and volatility index. Operating cash flow increased 89.8% from $5.07M to $9.63M, EBIT increased 21.1% from $11.87M to $14.38M, and earnings per share increased from $0.44 to $0.52.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 8/15/2024 due to an increase in the valuation index, growth index and volatility index. Operating cash flow increased 89.8% from $5.07M to $9.63M, EBIT increased 21.1% from $11.87M to $14.38M, and earnings per share increased from $0.44 to $0.52.
C
Hold
7/17/2024Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 7/17/2024 due to a decline in the valuation index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 7/17/2024 due to a decline in the valuation index.
B
Buy
7/2/2024Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 7/2/2024 due to an increase in the total return index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 7/2/2024 due to an increase in the total return index.
C
Hold
6/3/2024Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 6/3/2024 due to a decline in the valuation index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 6/3/2024 due to a decline in the valuation index.
B
Buy
5/17/2024Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 5/17/2024 due to a noticeable increase in the total return index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 5/17/2024 due to a noticeable increase in the total return index.
C
Hold
4/29/2024Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 4/29/2024 due to a decline in the total return index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 4/29/2024 due to a decline in the total return index.
B
Buy
4/12/2024Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 4/12/2024 due to a large increase in the total return index and valuation index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 4/12/2024 due to a large increase in the total return index and valuation index.
C
Hold
3/25/2024Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 3/25/2024 due to a large decline in the total return index, volatility index and valuation index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 3/25/2024 due to a large decline in the total return index, volatility index and valuation index.
B
Buy
3/7/2024Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 3/7/2024 due to a significant increase in the total return index and growth index. Earnings per share increased from $0.33 to $0.3699, EBIT increased 11.18% from $9.18M to $10.21M, and total revenue increased 3.1% from $47.41M to $48.88M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 3/7/2024 due to a significant increase in the total return index and growth index. Earnings per share increased from $0.33 to $0.3699, EBIT increased 11.18% from $9.18M to $10.21M, and total revenue increased 3.1% from $47.41M to $48.88M.
C
Hold
11/8/2023Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 11/8/2023 due to a decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.36 to $0.33, net income declined 7.36% from $8.1M to $7.5M, and total revenue declined 5.4% from $50.12M to $47.41M.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 11/8/2023 due to a decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.36 to $0.33, net income declined 7.36% from $8.1M to $7.5M, and total revenue declined 5.4% from $50.12M to $47.41M.
B
Buy
10/27/2023Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 10/27/2023 due to an increase in the valuation index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 10/27/2023 due to an increase in the valuation index and dividend index.
C
Hold
10/12/2023Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 10/12/2023 due to a decline in the volatility index and total return index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 10/12/2023 due to a decline in the volatility index and total return index.
B
Buy
9/22/2023Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 9/22/2023 due to an increase in the volatility index and valuation index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 9/22/2023 due to an increase in the volatility index and valuation index.
C
Hold
9/7/2023Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 9/7/2023 due to a major decline in the total return index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 9/7/2023 due to a major decline in the total return index.
B
Buy
8/9/2023Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 8/9/2023 due to a substantial increase in the growth index, valuation index and volatility index. Operating cash flow increased 422.29% from $2.28M to $11.9M, earnings per share increased from $0.27 to $0.36, and EBIT increased 17.77% from $8.18M to $9.63M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 8/9/2023 due to a substantial increase in the growth index, valuation index and volatility index. Operating cash flow increased 422.29% from $2.28M to $11.9M, earnings per share increased from $0.27 to $0.36, and EBIT increased 17.77% from $8.18M to $9.63M.
C
Hold
4/12/2023Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 4/12/2023 due to a substantial increase in the total return index, growth index and volatility index. EBIT increased 13.28% from $6.15M to $6.97M, total revenue increased 4.93% from $39.03M to $40.95M, and earnings per share increased from $0.2482 to $0.2499.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 4/12/2023 due to a substantial increase in the total return index, growth index and volatility index. EBIT increased 13.28% from $6.15M to $6.97M, total revenue increased 4.93% from $39.03M to $40.95M, and earnings per share increased from $0.2482 to $0.2499.
C
Hold
8/8/2022Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 8/8/2022 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $0.27 to $0.16.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 8/8/2022 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $0.27 to $0.16.
C
Hold
11/8/2021Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 11/8/2021 due to a major decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.4 to $0.3, net income declined 21.63% from $8.3M to $6.5M, and EBIT declined 18.31% from $11.11M to $9.07M.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 11/8/2021 due to a major decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.4 to $0.3, net income declined 21.63% from $8.3M to $6.5M, and EBIT declined 18.31% from $11.11M to $9.07M.
B
Buy
9/29/2021Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B- from B on 9/29/2021 due to a significant decline in the total return index and volatility index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B- from B on 9/29/2021 due to a significant decline in the total return index and volatility index.
B
Buy
8/3/2021Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B from B- on 8/3/2021 due to a large increase in the total return index, valuation index and solvency index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B from B- on 8/3/2021 due to a large increase in the total return index, valuation index and solvency index.
B
Buy
7/13/2021Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 7/13/2021 due to a noticeable increase in the total return index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 7/13/2021 due to a noticeable increase in the total return index.
C
Hold
6/22/2021Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 6/22/2021 due to a decline in the valuation index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 6/22/2021 due to a decline in the valuation index and dividend index.
B
Buy
5/12/2021Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 5/12/2021 due to a large increase in the total return index, valuation index and solvency index. Debt to equity declined from 0.23 to 0.19, and the quick ratio increased from 1.85 to 1.97.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 5/12/2021 due to a large increase in the total return index, valuation index and solvency index. Debt to equity declined from 0.23 to 0.19, and the quick ratio increased from 1.85 to 1.97.
C
Hold
12/1/2020Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 12/1/2020 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 163.92% from $5.35M to $14.11M, earnings per share increased from $0.17 to $0.37, and EBIT increased 57.25% from $6.07M to $9.55M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 12/1/2020 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 163.92% from $5.35M to $14.11M, earnings per share increased from $0.17 to $0.37, and EBIT increased 57.25% from $6.07M to $9.55M.
C
Hold
8/17/2020Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C from C- on 8/17/2020 due to a substantial increase in the growth index, volatility index and total return index. Operating cash flow increased 349.71% from $1.19M to $5.35M, EBIT increased 39.49% from $4.35M to $6.07M, and earnings per share increased from $0.1574 to $0.17.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C from C- on 8/17/2020 due to a substantial increase in the growth index, volatility index and total return index. Operating cash flow increased 349.71% from $1.19M to $5.35M, EBIT increased 39.49% from $4.35M to $6.07M, and earnings per share increased from $0.1574 to $0.17.
C
Hold
6/2/2020Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C- from C on 6/2/2020 due to a large decline in the total return index, growth index and valuation index. Operating cash flow declined 78.75% from $5.59M to $1.19M, earnings per share declined from $0.2199 to $0.1574, and EBIT declined 11.67% from $4.93M to $4.35M.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C- from C on 6/2/2020 due to a large decline in the total return index, growth index and valuation index. Operating cash flow declined 78.75% from $5.59M to $1.19M, earnings per share declined from $0.2199 to $0.1574, and EBIT declined 11.67% from $4.93M to $4.35M.
C
Hold
3/12/2020Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 3/12/2020 due to a decline in the volatility index and total return index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 3/12/2020 due to a decline in the volatility index and total return index.
C
Hold
2/26/2020Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 2/26/2020 due to an increase in the valuation index, volatility index and total return index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 2/26/2020 due to an increase in the valuation index, volatility index and total return index.
C
Hold
2/11/2020Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 2/11/2020 due to a large decline in the total return index and volatility index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 2/11/2020 due to a large decline in the total return index and volatility index.
C
Hold
1/14/2020Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 1/14/2020 due to a decline in the growth index, efficiency index and valuation index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 1/14/2020 due to a decline in the growth index, efficiency index and valuation index.
B
Buy
12/4/2019Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 12/4/2019 due to a large increase in the total return index, volatility index and valuation index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 12/4/2019 due to a large increase in the total return index, volatility index and valuation index.
C
Hold
10/24/2019Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 10/24/2019 due to a substantial increase in the growth index, efficiency index and volatility index. Operating cash flow increased 2,079% from -$219 to $4.33M, earnings per share increased from $0.17 to $0.23, and EBIT increased 33.37% from $4.44M to $5.92M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 10/24/2019 due to a substantial increase in the growth index, efficiency index and volatility index. Operating cash flow increased 2,079% from -$219 to $4.33M, earnings per share increased from $0.17 to $0.23, and EBIT increased 33.37% from $4.44M to $5.92M.
C
Hold
5/8/2019Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 5/8/2019 due to a significant decline in the growth index and efficiency index. Operating cash flow declined 103.33% from $6.57M to -$219, net income declined 41.69% from $6.03M to $3.51M, and earnings per share declined from $0.2902 to $0.17.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 5/8/2019 due to a significant decline in the growth index and efficiency index. Operating cash flow declined 103.33% from $6.57M to -$219, net income declined 41.69% from $6.03M to $3.51M, and earnings per share declined from $0.2902 to $0.17.
C
Hold
3/13/2019Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 3/13/2019 due to a noticeable increase in the growth index, volatility index and valuation index. Operating cash flow increased 52.53% from $4.31M to $6.57M, earnings per share increased from $0.21 to $0.2902, and EBIT increased 21.29% from $4.61M to $5.6M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 3/13/2019 due to a noticeable increase in the growth index, volatility index and valuation index. Operating cash flow increased 52.53% from $4.31M to $6.57M, earnings per share increased from $0.21 to $0.2902, and EBIT increased 21.29% from $4.61M to $5.6M.
C
Hold
3/7/2019Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 3/7/2019 due to a decline in the valuation index, volatility index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 3/7/2019 due to a decline in the valuation index, volatility index and dividend index.
C
Hold
2/20/2019Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 2/20/2019 due to an increase in the total return index and volatility index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 2/20/2019 due to an increase in the total return index and volatility index.
C
Hold
1/7/2019Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 1/7/2019 due to a decline in the volatility index and total return index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 1/7/2019 due to a decline in the volatility index and total return index.
C
Hold
12/18/2018Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 12/18/2018 due to a decline in the volatility index and total return index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 12/18/2018 due to a decline in the volatility index and total return index.
B
Buy
11/6/2018Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B- from B on 11/6/2018 due to a substantial decline in the total return index, growth index and efficiency index. Earnings per share declined from $0.43 to $0.21, net income declined 50.7% from $8.75M to $4.31M, and EBIT declined 18.57% from $5.67M to $4.61M.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B- from B on 11/6/2018 due to a substantial decline in the total return index, growth index and efficiency index. Earnings per share declined from $0.43 to $0.21, net income declined 50.7% from $8.75M to $4.31M, and EBIT declined 18.57% from $5.67M to $4.61M.
B
Buy
5/7/2018Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 5/7/2018 due to a substantial decline in the total return index, growth index and efficiency index. Operating cash flow declined 44.59% from $6.77M to $3.75M, EBIT declined 15.03% from $5.72M to $4.86M, and net income declined 10.06% from $4.28M to $3.85M.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 5/7/2018 due to a substantial decline in the total return index, growth index and efficiency index. Operating cash flow declined 44.59% from $6.77M to $3.75M, EBIT declined 15.03% from $5.72M to $4.86M, and net income declined 10.06% from $4.28M to $3.85M.
B
Buy
4/20/2018Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 4/20/2018 due to a major increase in the total return index and efficiency index. Total capital increased 3.45% from $106.11M to $109.77M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 4/20/2018 due to a major increase in the total return index and efficiency index. Total capital increased 3.45% from $106.11M to $109.77M.
B
Buy
11/6/2017Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 11/6/2017 due to a substantial decline in the total return index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 11/6/2017 due to a substantial decline in the total return index and dividend index.
B
Buy
7/21/2017Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 7/21/2017 due to a noticeable increase in the total return index, volatility index and valuation index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 7/21/2017 due to a noticeable increase in the total return index, volatility index and valuation index.
B
Buy
6/7/2017Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 6/7/2017 due to a decline in the total return index and valuation index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 6/7/2017 due to a decline in the total return index and valuation index.
B
Buy
5/23/2017Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 5/23/2017 due to a noticeable increase in the total return index, efficiency index and volatility index. Net income increased 23.95% from $2.6M to $3.22M, and total capital increased 4.71% from $87.5M to $91.62M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 5/23/2017 due to a noticeable increase in the total return index, efficiency index and volatility index. Net income increased 23.95% from $2.6M to $3.22M, and total capital increased 4.71% from $87.5M to $91.62M.
B
Buy
2/28/2017Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 2/28/2017 due to a large decline in the total return index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 2/28/2017 due to a large decline in the total return index.
B
Buy
1/30/2017Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 1/30/2017 due to a noticeable increase in the total return index, valuation index and volatility index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 1/30/2017 due to a noticeable increase in the total return index, valuation index and volatility index.
B
Buy
1/13/2017Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 1/13/2017 due to a decline in the total return index, valuation index and volatility index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 1/13/2017 due to a decline in the total return index, valuation index and volatility index.
B
Buy
12/29/2016Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 12/29/2016 due to an increase in the total return index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 12/29/2016 due to an increase in the total return index.
B
Buy
12/14/2016Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 12/14/2016 due to a noticeable decline in the valuation index, volatility index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 12/14/2016 due to a noticeable decline in the valuation index, volatility index and dividend index.
B
Buy
8/8/2016Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 8/8/2016 due to a significant increase in the total return index, growth index and valuation index. Operating cash flow increased 304.93% from $1.26M to $5.09M, earnings per share increased from $0.11 to $0.14, and EBIT increased 14.64% from $3.3M to $3.78M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 8/8/2016 due to a significant increase in the total return index, growth index and valuation index. Operating cash flow increased 304.93% from $1.26M to $5.09M, earnings per share increased from $0.11 to $0.14, and EBIT increased 14.64% from $3.3M to $3.78M.
B
Buy
4/25/2016Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 4/25/2016 due to a significant decline in the total return index, valuation index and volatility index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 4/25/2016 due to a significant decline in the total return index, valuation index and volatility index.
B
Buy
4/8/2016Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 4/8/2016 due to a noticeable increase in the total return index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 4/8/2016 due to a noticeable increase in the total return index.
B
Buy
3/11/2016Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from A on 3/11/2016 due to a major decline in the volatility index and total return index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from A on 3/11/2016 due to a major decline in the volatility index and total return index.
A
Buy
1/13/2016Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to A from A- on 1/13/2016 due to an increase in the valuation index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to A from A- on 1/13/2016 due to an increase in the valuation index.
A
Buy
12/29/2015Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to A- from A on 12/29/2015 due to a decline in the valuation index, total return index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to A- from A on 12/29/2015 due to a decline in the valuation index, total return index and dividend index.
A
Buy
11/30/2015Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to A from A+ on 11/30/2015 due to a decline in the valuation index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to A from A+ on 11/30/2015 due to a decline in the valuation index and dividend index.
A
Buy
11/9/2015Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to A+ from A on 11/9/2015 due to a noticeable increase in the total return index, valuation index and efficiency index. Net income increased 18.39% from $1.77M to $2.09M, and total capital increased 5.32% from $70.44M to $74.19M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to A+ from A on 11/9/2015 due to a noticeable increase in the total return index, valuation index and efficiency index. Net income increased 18.39% from $1.77M to $2.09M, and total capital increased 5.32% from $70.44M to $74.19M.
A
Buy
10/20/2015Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to A from A+ on 10/20/2015 due to a noticeable decline in the total return index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to A from A+ on 10/20/2015 due to a noticeable decline in the total return index.
A
Buy
10/5/2015Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to A+ from A on 10/5/2015 due to an increase in the valuation index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to A+ from A on 10/5/2015 due to an increase in the valuation index and dividend index.
A
Buy
8/24/2015Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to A from A+ on 8/24/2015 due to a decline in the volatility index, valuation index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to A from A+ on 8/24/2015 due to a decline in the volatility index, valuation index and dividend index.
A
Buy
8/7/2015Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to A+ from A on 8/7/2015 due to a major increase in the growth index, total return index and volatility index. Earnings per share increased from $0.0786 to $0.1, EBIT increased 21% from $2.31M to $2.79M, and total revenue increased 5.05% from $18.77M to $19.71M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to A+ from A on 8/7/2015 due to a major increase in the growth index, total return index and volatility index. Earnings per share increased from $0.0786 to $0.1, EBIT increased 21% from $2.31M to $2.79M, and total revenue increased 5.05% from $18.77M to $19.71M.
A
Buy
5/28/2015Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to A from A- on 5/28/2015 due to a large increase in the total return index, valuation index and efficiency index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to A from A- on 5/28/2015 due to a large increase in the total return index, valuation index and efficiency index.
A
Buy
5/8/2015Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to A- from B on 5/8/2015 due to a large increase in the total return index, volatility index and solvency index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to A- from B on 5/8/2015 due to a large increase in the total return index, volatility index and solvency index.
B
Buy
4/23/2015Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 4/23/2015 due to a decline in the valuation index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B from B+ on 4/23/2015 due to a decline in the valuation index and dividend index.
B
Buy
3/23/2015Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 3/23/2015 due to an increase in the volatility index, valuation index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B+ from B on 3/23/2015 due to an increase in the volatility index, valuation index and dividend index.
B
Buy
3/20/2015Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B from C+ on 3/20/2015 due to a significant increase in the growth index, valuation index and efficiency index. Earnings per share increased from $0.05 to $0.1072, net income increased 105.14% from $934 to $1.92M, and EBIT increased 41.79% from $2M to $2.83M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B from C+ on 3/20/2015 due to a significant increase in the growth index, valuation index and efficiency index. Earnings per share increased from $0.05 to $0.1072, net income increased 105.14% from $934 to $1.92M, and EBIT increased 41.79% from $2M to $2.83M.
C
Hold
3/19/2015Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 3/19/2015 due to a decline in the valuation index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 3/19/2015 due to a decline in the valuation index and dividend index.
B
Buy
3/4/2015Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 3/4/2015 due to a major increase in the volatility index and total return index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 3/4/2015 due to a major increase in the volatility index and total return index.
C
Hold
12/4/2014Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 12/4/2014 due to an increase in the volatility index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 12/4/2014 due to an increase in the volatility index.
C
Hold
11/19/2014Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 11/19/2014 due to a major decline in the growth index, total return index and volatility index. Earnings per share declined from $0.0789 to $0.05, EBIT declined 18.75% from $2.46M to $2M, and total revenue declined 3.68% from $17.99M to $17.32M.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 11/19/2014 due to a major decline in the growth index, total return index and volatility index. Earnings per share declined from $0.0789 to $0.05, EBIT declined 18.75% from $2.46M to $2M, and total revenue declined 3.68% from $17.99M to $17.32M.
C
Hold
9/2/2014Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 9/2/2014 due to a decline in the volatility index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 9/2/2014 due to a decline in the volatility index.
B
Buy
8/18/2014Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 8/18/2014 due to an increase in the volatility index and valuation index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to B- from C+ on 8/18/2014 due to an increase in the volatility index and valuation index.
C
Hold
8/15/2014Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 8/15/2014 due to a major increase in the growth index, valuation index and solvency index. EBIT increased 1,329.65% from $172 to $2.46M, the quick ratio increased from 2.64 to 3.87, and total revenue increased 8.41% from $16.59M to $17.99M.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 8/15/2014 due to a major increase in the growth index, valuation index and solvency index. EBIT increased 1,329.65% from $172 to $2.46M, the quick ratio increased from 2.64 to 3.87, and total revenue increased 8.41% from $16.59M to $17.99M.
C
Hold
8/12/2014Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 8/12/2014 due to a decline in the volatility index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 8/12/2014 due to a decline in the volatility index.
C
Hold
7/28/2014Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 7/28/2014 due to an increase in the volatility index, valuation index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 7/28/2014 due to an increase in the volatility index, valuation index and dividend index.
C
Hold
7/10/2014Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 7/10/2014 due to a decline in the valuation index, volatility index and total return index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 7/10/2014 due to a decline in the valuation index, volatility index and total return index.
C
Hold
6/25/2014Upgraded
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 6/25/2014 due to an increase in the valuation index, volatility index and dividend index.
LeMaitre Vascular, Inc. (LMAT) was upgraded to C+ from C on 6/25/2014 due to an increase in the valuation index, volatility index and dividend index.
C
Hold
5/23/2014Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 5/23/2014 due to a decline in the volatility index.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C from C+ on 5/23/2014 due to a decline in the volatility index.
C
Hold
5/16/2014Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 5/16/2014 due to a major decline in the growth index, valuation index and volatility index. Operating cash flow declined 224.56% from $1.36M to -$1.69M, earnings per share declined from $0.0402 to -$0.0133, and EBIT declined 85.32% from $1.17M to $172.
LeMaitre Vascular, Inc. (LMAT) was downgraded to C+ from B- on 5/16/2014 due to a major decline in the growth index, valuation index and volatility index. Operating cash flow declined 224.56% from $1.36M to -$1.69M, earnings per share declined from $0.0402 to -$0.0133, and EBIT declined 85.32% from $1.17M to $172.
B
Buy
4/16/2014Downgrade
LeMaitre Vascular, Inc. (LMAT) was downgraded to B- from B on 4/16/2014 due to a decline in the growth index, valuation index and solvency index. Operating cash flow declined 43.29% from $2.39M to $1.36M, and earnings per share declined from $0.047 to $0.0402.
LeMaitre Vascular, Inc. (LMAT) was downgraded to B- from B on 4/16/2014 due to a decline in the growth index, valuation index and solvency index. Operating cash flow declined 43.29% from $2.39M to $1.36M, and earnings per share declined from $0.047 to $0.0402.
NASDAQ
03/13/2025 4:00PM Eastern
Quotes delayed
